Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Mr Sekiguchi Explains PhRMA's Stance Regarding NHI Pricing
November 5, 2007
- MEDICAL DEVICE NEWS IN BRIEF
November 5, 2007
- Novartis to Cut 1,260 Jobs in the US
November 5, 2007
- R&D NEWS IN BRIEF
November 5, 2007
- GSK to Save ￡700 Mil. Each Year from 2010
November 5, 2007
- Paltac to Stimulate OTC Drug Market by Merging with Kobashou
October 29, 2007
- MR Education Center Considers Radical Reform of MR Education System
October 29, 2007
- R&D NEWS IN BRIEF
October 29, 2007
- SEMINAR／Generics to Obtain 1/3 of Market for Antibacterials in 2016: Datamonitor
October 29, 2007
- Korosho to Increase Multinational Joint Trial Participation Rate under 5-Year Plan
October 29, 2007
- Consumption of EPO Decreased in 40% of Patients
October 29, 2007
- OHARA Pharm. Strengthens Product, Information Supply Systems
October 29, 2007
- Merck Ties UP with ImClone, BMS for Erbitux in Japan
October 29, 2007
- JGPMA Announces Goals to Promote Use of Generics
October 29, 2007
- Shionogi's Doripenem Debuts in US Market
October 29, 2007
- SURVEY／Analysis of Medical Bills Show Increases in Use of Generics: Korosho
October 29, 2007
- Infection-related Test Market for 2006 Reaches ¥82.5 Bil.: Fuji Keizai
October 29, 2007
- Action Program Issued by Korosho to Promote Use of Generics
October 29, 2007
- Kirin Pharma to Merge with Kyowa Hakko
October 29, 2007
- Korosho Presents List of Issues to Promote Use of Generics to Chuikyo
October 29, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…